Table of Content

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. HOSPITALS ARE THE LARGEST REVENUE GENERATING END USER
3.2.2. SPINAL FUSION IS THE FASTEST GROWING APPLICATION
3.2.3. VISCOSUPPLEMENTATION HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS

4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. INCREASING GERIATRIC POPULATION
4.2.2. INCREASE ORTHOPAEDIC RELATED DISEASES DUE TO LIFESTYLE CHOICES
4.2.3. TECHNOLOGICAL ADVANCEMENT
4.3. MARKET RESTRAINTS
4.3.1. STRINGENT GOVERNMENT POLICIES
4.3.2. POST-SURGERY COMPLICATIONS
4.3.3. HIGH COST OF ORTHOPEDICS IMPLANTS
4.4. MARKET OPPORTUNITIES
4.4.1. INCREASED UTILIZATION OF BONE REGENERATION TECHNOLOGY
4.4.2. GROWING DISPOSABLE INCOME
4.4.3. EXPANSION OF COST EFFECTIVE MEDICAL PRODUCTS
4.4.4. HUGE MARKET OPPORTUNITIES IN DEVELOPING COUNTRIES
4.5. MARKET CHALLENGES
4.5.1. HIGH COST OF SPINAL FUSION SURGERY
4.5.2. POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE

5. MARKET BY END-USER
5.1. HOSPITALS
5.2. ORTHOPEDIC CLINICS

6. MARKET BY PRODUCTS
6.1. DEMINERALIZED BONE MATRIX (DBM)
6.2. ALLOGRAFT
6.3. BONE MORPHOGENETIC PROTEIN (BMP)
6.4. VISCOSUPPLEMENTATION
6.5. SYNTHETIC BONE SUBSTITUTES
6.6. STEM CELL THERAPY
6.7. OTHER PRODUCTS

7. MARKET BY APPLICATION
7.1. SPINAL FUSION
7.2. TRAUMA REPAIR
7.3. RECONSTRUCTIVE SURGERY
7.4. TENDON AND LIGAMENT
7.5. OTHER APPLICATIONS

8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF BUYER
8.1.4. BARGAINING POWER OF SUPPLIER
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. PESTEL ANALYSIS
8.3. PATENT ANALYSIS
8.4. KEY BUYING CRITERIA
8.5. VALUE CHAIN ANALYSIS
8.6. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. THE UNITED KINGDOM
9.1.2. FRANCE
9.1.3. GERMANY
9.1.4. SPAIN
9.1.5. ITALY
9.1.6. REST OF EUROPE

10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. COMPANY PROFILES
10.2.1. AAP IMPLANTATE AG
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT PORTFOLIO
10.2.1.3. SCOT ANALYSIS
10.2.2. ALLOSOURCE
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT PORTFOLIO
10.2.2.3. SCOT ANALYSIS
10.2.2.4. STRATEGIC INITIATIVE
10.2.3. AMEDICA CORPORATION
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCT PORTFOLIO
10.2.3.3. SCOT ANALYSIS
10.2.3.4. STRATEGIC INITIATIVES
10.2.4. BAXTER INTERNATIONAL INC.
10.2.4.1. MARKET OVERVIEW
10.2.4.2. PRODUCT PORTFOLIO
10.2.4.3. SCOT ANALYSIS
10.2.4.4. STRATEGIC INITIATIVES
10.2.5. CONMED CORPORATION
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT PORTFOLIO
10.2.6. DEPUY INC. (ACQUIRED BY JOHNSON AND JOHNSON)
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCT PORTFOLIO
10.2.6.3. SCOT ANALYSIS
10.2.6.4. STRATEGIC INITIATIVES
10.2.7. EXACTECH INC.
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCT PORTFOLIO
10.2.7.3. STRATEGIC INITIATIVES
10.2.8. INTEGRA LIFESCIENCES HOLDING CORPORATION
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT PORTFOLIO
10.2.8.3. SCOT ANALYSIS
10.2.8.4. STRATEGIC INITIATIVES
10.2.9. MEDTRONIC INC.
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCT PORTFOLIO
10.2.9.3. STRATEGIC INITIATIVES
10.2.10. NUVASIVE INC.
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCT PORTFOLIO
10.2.10.3. SCOT ANALYSIS
10.2.10.4. STRATEGIC INITIATIVES
10.2.11. RTI SURGICAL
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCT PORTFOLIO
10.2.11.3. SCOT ANALYSIS
10.2.11.4. STRATEGIC INITIATIVES
10.2.12. SANOFI
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCT PORTFOLIO
10.2.12.3. SCOT ANALYSIS
10.2.12.4. STRATEGIC INITIATIVES
10.2.13. SMITH & NEPHEW PLC
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. PRODUCT PORTFOLIO
10.2.13.3. STRATEGIC INITIATIVES
10.2.14. STRYKER CORPORATION
10.2.14.1. COMPANY OVERVIEW
10.2.14.2. PRODUCT PORTFOLIO
10.2.14.3. STRATEGIC INITIATIVES
10.2.15. ZIMMER BIOMET INC.
10.2.15.1. COMPANY OVERVIEW
10.2.15.2. PRODUCT PORTFOLIO
10.2.15.3. SCOT ANALYSIS
10.2.15.4. STRATEGIC INITIATIVES

TABLE LIST
TABLE 1 EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
TABLE 2 POST-SURGERY COMPLICATION
TABLE 3 EUROPE ORTHOBIOLOGICS MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 4 EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE ORTHOPEDIC CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 6 EUROPE ORTHOBIOLOGICS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 7 EUROPE DEMINERALIZED BONE MATRIX (DBM) MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE ALLOGRAFT MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE BONE MORPHOGENETIC PROTEIN (BMP) MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE VISCOSUPPLEMENTATION MARKET 2019-2027 ($ MILLION)
TABLE 11 EUROPE SYNTHETIC BONE SUBSTITUTES MARKET 2019-2027 ($ MILLION)
TABLE 12 EUROPE STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 14 EUROPE ORTHOBIOLOGICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 EUROPE SPINAL FUSION MARKET 2019-2027 ($ MILLION)
TABLE 16 EUROPE TRAUMA REPAIR MARKET 2019-2027 ($ MILLION)
TABLE 17 EUROPE RECONSTRUCTIVE SURGERY MARKET 2019-2027 ($ MILLION)
TABLE 18 EUROPE TENDON AND LIGAMENT MARKET 2019-2027 ($ MILLION)
TABLE 19 EUROPE OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 20 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 AGE STRUCTURE OF GERMANY 2017

FIGURES LIST
FIGURE 1 EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 3 EUROPE ORTHOBIOLOGICS MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 4 EUROPE ORTHOBIOLOGICS MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 5 EUROPE ORTHOBIOLOGICS MARKET BY ORTHOPEDIC CLINICS 2019-2027 ($ MILLION)
FIGURE 6 EUROPE ORTHOBIOLOGICS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 7 EUROPE ORTHOBIOLOGICS MARKET BY DEMINERALIZED BONE MATRIX (DBM) 2019-2027 ($ MILLION)
FIGURE 8 EUROPE ORTHOBIOLOGICS MARKET BY ALLOGRAFT 2019-2027 ($ MILLION)
FIGURE 9 EUROPE ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEIN (BMP) 2019-2027 ($ MILLION)
FIGURE 10 EUROPE ORTHOBIOLOGICS MARKET BY VISCOSUPPLEMENTATION 2019-2027 ($ MILLION)
FIGURE 11 EUROPE ORTHOBIOLOGICS MARKET BY SYNTHETIC BONE SUBSTITUTES 2019-2027 ($ MILLION)
FIGURE 12 EUROPE ORTHOBIOLOGICS MARKET BY STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 13 EUROPE ORTHOBIOLOGICS MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 14 EUROPE ORTHOBIOLOGICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 EUROPE ORTHOBIOLOGICS MARKET BY SPINAL FUSION 2019-2027 ($ MILLION)
FIGURE 16 EUROPE ORTHOBIOLOGICS MARKET BY TRAUMA REPAIR 2019-2027 ($ MILLION)

FIGURE 17 EUROPE ORTHOBIOLOGICS MARKET BY RECONSTRUCTIVE SURGERY 2019-2027 ($ MILLION)
FIGURE 18 EUROPE ORTHOBIOLOGICS MARKET BY TENDON AND LIGAMENT 2019-2027 ($ MILLION)
FIGURE 19 EUROPE ORTHOBIOLOGICS MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 20 PORTER’S FIVE FORCE MODEL
FIGURE 21 EUROPE ORTHOBIOLOGICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 22 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2018 & 2027
FIGURE 23 THE UNITED KINGDOM ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 24 FRANCE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 25 GERMANY ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 SPAIN ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)
FIGURE 27 ITALY ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)
FIGURE 28 REST OF EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 29 ORTHOBIOLOGICS COMPANY MARKET SHARE 2018 (% )
 



List of Figures


FIGURES LIST
FIGURE 1 EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 3 EUROPE ORTHOBIOLOGICS MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 4 EUROPE ORTHOBIOLOGICS MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 5 EUROPE ORTHOBIOLOGICS MARKET BY ORTHOPEDIC CLINICS 2019-2027 ($ MILLION)
FIGURE 6 EUROPE ORTHOBIOLOGICS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 7 EUROPE ORTHOBIOLOGICS MARKET BY DEMINERALIZED BONE MATRIX (DBM) 2019-2027 ($ MILLION)
FIGURE 8 EUROPE ORTHOBIOLOGICS MARKET BY ALLOGRAFT 2019-2027 ($ MILLION)
FIGURE 9 EUROPE ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEIN (BMP) 2019-2027 ($ MILLION)
FIGURE 10 EUROPE ORTHOBIOLOGICS MARKET BY VISCOSUPPLEMENTATION 2019-2027 ($ MILLION)
FIGURE 11 EUROPE ORTHOBIOLOGICS MARKET BY SYNTHETIC BONE SUBSTITUTES 2019-2027 ($ MILLION)
FIGURE 12 EUROPE ORTHOBIOLOGICS MARKET BY STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 13 EUROPE ORTHOBIOLOGICS MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 14 EUROPE ORTHOBIOLOGICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 EUROPE ORTHOBIOLOGICS MARKET BY SPINAL FUSION 2019-2027 ($ MILLION)
FIGURE 16 EUROPE ORTHOBIOLOGICS MARKET BY TRAUMA REPAIR 2019-2027 ($ MILLION)

FIGURE 17 EUROPE ORTHOBIOLOGICS MARKET BY RECONSTRUCTIVE SURGERY 2019-2027 ($ MILLION)
FIGURE 18 EUROPE ORTHOBIOLOGICS MARKET BY TENDON AND LIGAMENT 2019-2027 ($ MILLION)
FIGURE 19 EUROPE ORTHOBIOLOGICS MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 20 PORTER’S FIVE FORCE MODEL
FIGURE 21 EUROPE ORTHOBIOLOGICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 22 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2018 & 2027
FIGURE 23 THE UNITED KINGDOM ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 24 FRANCE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 25 GERMANY ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 SPAIN ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)
FIGURE 27 ITALY ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)
FIGURE 28 REST OF EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 29 ORTHOBIOLOGICS COMPANY MARKET SHARE 2018 (% )

 

List of Tables


TABLE LIST
TABLE 1 EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
TABLE 2 POST-SURGERY COMPLICATION
TABLE 3 EUROPE ORTHOBIOLOGICS MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 4 EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE ORTHOPEDIC CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 6 EUROPE ORTHOBIOLOGICS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 7 EUROPE DEMINERALIZED BONE MATRIX (DBM) MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE ALLOGRAFT MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE BONE MORPHOGENETIC PROTEIN (BMP) MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE VISCOSUPPLEMENTATION MARKET 2019-2027 ($ MILLION)
TABLE 11 EUROPE SYNTHETIC BONE SUBSTITUTES MARKET 2019-2027 ($ MILLION)
TABLE 12 EUROPE STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 14 EUROPE ORTHOBIOLOGICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 EUROPE SPINAL FUSION MARKET 2019-2027 ($ MILLION)
TABLE 16 EUROPE TRAUMA REPAIR MARKET 2019-2027 ($ MILLION)
TABLE 17 EUROPE RECONSTRUCTIVE SURGERY MARKET 2019-2027 ($ MILLION)
TABLE 18 EUROPE TENDON AND LIGAMENT MARKET 2019-2027 ($ MILLION)
TABLE 19 EUROPE OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 20 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 AGE STRUCTURE OF GERMANY 2017